1 – 243 of 243
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A pilot study of an organised population‐based testing programme for prostate cancer
(
- Contribution to journal › Article
-
Mark
Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management : A PIONEER Analysis Based on Big Data
(
- Contribution to journal › Article
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Evaluation of superficial xenograft volume estimation by ultrasound and caliper against MRI in a longitudinal pre-clinical radiotherapeutic setting
(
- Contribution to journal › Article
-
Mark
Investigating Ras homolog gene family member C (RhoC) and Ki67 expression following external beam radiation therapy show increased RhoC expression in relapsing prostate cancer xenografts
(
- Contribution to journal › Article
-
Mark
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography : Results of a Multicenter European Study
(
- Contribution to journal › Article
-
Mark
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
(
- Contribution to journal › Article
-
Mark
Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study
(
- Contribution to journal › Article
-
Mark
Deep learning performance on MRI prostate gland segmentation : evaluation of two commercially available algorithms compared with an expert radiologist
(
- Contribution to journal › Article
-
Mark
European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Апалутамид в комбинации с андрогендепривационной терапией в клинических подгруппах пациентов с метастатическим кастрационно-чувствительным раком предстательной железы : подгрупповой анализ рандомизированного клинического исследования TITAN
(
- Contribution to journal › Article
- 2023
-
Mark
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence : The PET index
(
- Contribution to journal › Article
-
Mark
Systematic Augmentation in HSV Space for Semantic Segmentation of Prostate Biopsies
2023) 22nd Scandinavian Conference on Image Analysis, SCIA 2023 In Lecture Notes in Computer Science 13886. p.293-308(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer
(
- Contribution to journal › Article
-
Mark
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Salvage radiotherapy after radical prostatectomy : functional outcomes in the LAPPRO trial after 8-year follow-up
(
- Contribution to journal › Article
-
Mark
Re : Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intake of the Total, Classes, and Subclasses of (Poly)Phenols and Risk of Prostate Cancer : A Prospective Analysis of the EPIC Study
(
- Contribution to journal › Article
-
Mark
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
(
- Contribution to journal › Article
-
Mark
Correlation between ADC, ADC ratio, and Gleason Grade group in prostate cancer patients undergoing radical prostatectomy : Retrospective multicenter study with different MRI scanners
(
- Contribution to journal › Article
-
Mark
Deep learning algorithm performs similarly to radiologists in the assessment of prostate volume on MRI
(
- Contribution to journal › Article
-
Mark
Protein and amino acid intakes in relation to prostate cancer risk and mortality—A prospective study in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations : The EAU-RF NIMBUS Trial
(
- Contribution to journal › Article
-
Mark
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer : A subgroup analysis of the randomised clinical TITAN study
(
- Contribution to journal › Article
-
Mark
Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium
(
- Contribution to journal › Article
-
Mark
Acoustic enrichment of heterogenous circulating tumor cells and clusters from patients with metastatic prostate cancer
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Acoustophoresis enrichment of tumor cell clusters in blood of patients with metastatic prostate cancer
2023) The 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2023)(
- Contribution to conference › Abstract
-
Mark
Acoustophoresis enriches tumor cell clusters in blood of patients with prostate cancer
2023) Acoustofluidics Conference 2023, St. Louis USA(
- Contribution to conference › Abstract
- 2022
-
Mark
Risk of hernia formation after radical prostatectomy : a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial
(
- Contribution to journal › Article
-
Mark
Analytical performance of aPROMISE : automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting
(
- Contribution to journal › Article
-
Mark
Detection of lymph node metastases in patients with prostate cancer : Comparing conventional and digital [18F]-fluorocholine PET-CT using histopathology as a reference
(
- Contribution to journal › Article
-
Mark
Designing and Implementing a Population-based Organised Prostate Cancer Testing Programme
(
- Contribution to journal › Article
-
Mark
Learning curve for robot-assisted laparoscopic radical prostatectomy in a large prospective multicentre study
(
- Contribution to journal › Article
-
Mark
Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate Cancer
(
- Contribution to journal › Article
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
(
- Contribution to journal › Article
-
Mark
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
(
- Contribution to journal › Article
-
Mark
Nuclear expression of pSTAT3Tyr705 and pSTAT3Ser727 in the stromal compartment of localized hormone-naïve prostate cancer
(
- Contribution to journal › Article
-
Mark
Lymph swelling after radical prostatectomy and pelvic lymph node dissection
(
- Contribution to journal › Article
-
Mark
Establishing metastatic prostate cancer quality indicators using a modified Delphi approach
(
- Contribution to journal › Article
-
Mark
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
(
- Contribution to journal › Article
-
Mark
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer : Results from the Prospective, International, Observational Prostate Cancer Registry
(
- Contribution to journal › Article
-
Mark
Increasing rates of urinary- and bloodstream infections following transrectal prostate biopsy in South Sweden
(
- Contribution to journal › Article
-
Mark
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
(
- Contribution to journal › Article
-
Mark
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Diagnostic and prognostic factors in patients with prostate cancer : a systematic review
(
- Contribution to journal › Scientific review
-
Mark
Reply to Wei Zhang So, Ziting Wang, and Ho Yee Tiong's Letter to the Editor re : Anna Lantz, David Bock, Olof Akre, et al. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up. Eur Urol 2021;80:650–60
(
- Contribution to journal › Letter
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
(
- Contribution to journal › Article
-
Mark
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11
(
- Contribution to journal › Article
-
Mark
Vesicourethral Anastomotic Stenosis After Open or Robot-assisted Laparoscopic Retropubic Prostatectomy—Results from the Laparoscopic Prostatectomy Robot Open Trial
(
- Contribution to journal › Article
-
Mark
Quality of life with pharmacological treatment in patients with benign prostatic enlargement : results from the Evolution European Prospective Multicenter Multi-National Registry Study
(
- Contribution to journal › Article
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
(
- Contribution to journal › Article
-
Mark
Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category : results from the LAParoscopic prostatectomy robot and open trial
(
- Contribution to journal › Article
-
Mark
A retrospective study assessing the accuracy of [18F]–fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node dissection
(
- Contribution to journal › Article
-
Mark
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer : Analysis of Pain and Fatigue in the Phase 3 TITAN Study
(
- Contribution to journal › Article
-
Mark
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
(
- Contribution to journal › Article
-
Mark
Identification of a serum biomarker signature associated with metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
(
- Contribution to journal › Letter
-
Mark
An Artificial Intelligence-based Support Tool for Automation and Standardisation of Gleason Grading in Prostate Biopsies
(
- Contribution to journal › Article
-
Mark
Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial
(
- Contribution to journal › Article
-
Mark
IMAGINE—IMpact Assessment of Guidelines Implementation and Education : The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Contemporary use of phytotherapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia : results from the EVOLUTION European registry
(
- Contribution to journal › Article
-
Mark
Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume
(
- Contribution to journal › Article
-
Mark
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer : Data from the Prostate Cancer Registry
(
- Contribution to journal › Article
-
Mark
The Value of a New Diagnostic Test for Prostate Cancer : A Cost-Utility Analysis in Early Stage of Development
(
- Contribution to journal › Article
-
Mark
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer : Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(20). p.2294-2303(
- Contribution to journal › Article
-
Mark
Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer : 8-Year Follow-up
(
- Contribution to journal › Article
- 2020
-
Mark
Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition
(
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines Office : How We Ensure Transparent Conflict of Interest Disclosure and Management
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cytokines and Janus kinase/signal transducer and activator of transcription signaling in prostate cancer : overview and therapeutic opportunities
(
- Contribution to journal › Scientific review
-
Mark
A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study
(
- Contribution to journal › Article
-
Mark
Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases
(
- Contribution to journal › Article
-
Mark
STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
(
- Contribution to journal › Article
-
Mark
Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO
(
- Contribution to journal › Article
-
Mark
Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations : Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”
(
- Contribution to journal › Article
-
Mark
Introducing PIONEER : a project to harness big data in prostate cancer research
(
- Contribution to journal › Article
-
Mark
Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Domain-adversarial neural network for improved generalization performance of gleason grade classification
2020) Medical Imaging 2020: Digital Pathology In Progress in Biomedical Optics and Imaging - Proceedings of SPIE 11320.(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2019
-
Mark
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE) : a cost minimisation analysis
(
- Contribution to journal › Article
-
Mark
Quality of Life After Open Radical Prostatectomy Compared with Robot-assisted Radical Prostatectomy
(
- Contribution to journal › Article
-
Mark
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
(
- Contribution to journal › Article
-
Mark
90-Day readmission after radical prostatectomy—a prospective comparison between robot-assisted and open surgery
(
- Contribution to journal › Article
-
Mark
Expression of tSTAT3, pSTAT3
727
, and pSTAT3
705
in the epithelial cells of hormone-naïve prostate cancer
(
- Contribution to journal › Article
-
Mark
Proteogenomic characterization of patient-derived xenografts highlights the role of REST in neuroendocrine differentiation of castration-resistant prostate cancer
(
- Contribution to journal › Article
-
Mark
Agreement between patient reported outcomes and clinical reports after radical prostatectomy - A prospective longitudinal study
(
- Contribution to journal › Article
-
Mark
New Hope in Prostate Cancer Precision Medicine? miRNA Replacement and Epigenetics
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment : Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry
2019) In European Urology Focus(
- Contribution to journal › Article
-
Mark
The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells
(
- Contribution to journal › Article
-
Mark
The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
(
- Contribution to journal › Article
-
Mark
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN) : a randomised, placebo-controlled, phase 3 study
(
- Contribution to journal › Article
- 2018
-
Mark
Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men
(
- Contribution to journal › Article
-
Mark
Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy : Results from the LAParoscopic Prostatectomy Robot Open Trial
(
- Contribution to journal › Article
-
Mark
A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
Social constraints and psychological well-being after prostate cancer : A follow-up at 12 and 24 months after surgery
(
- Contribution to journal › Article
-
Mark
Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer a secondary analysis of a randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Health Economic Analysis of Open and Robot-assisted Laparoscopic Surgery for Prostate Cancer Within the Prospective Multicentre LAPPRO Trial
(
- Contribution to journal › Article
-
Mark
Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model : An Individual Patient Data Meta-Analysis
(
- Contribution to journal › Article
-
Mark
Generalization of prostate cancer classification for multiple sites using deep learning
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial
(
- Contribution to journal › Article
-
Mark
Role of serum response factor expression in prostate cancer biochemical recurrence
(
- Contribution to journal › Article
-
Mark
A phase III study of INCB054828 as adjuvant therapy in patients (pts) with high-risk urothelial carcinoma (UC) harboring fibroblast growth factor receptor 3 (FGFR3) genomic alterations
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.328-328(
- Contribution to journal › Article
- 2017
-
Mark
Automatic Gleason grading of H&E stained microscopic prostate images using deep convolutional neural networks
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Habits and self-assessed quality of life, negative intrusive thoughts and depressed mood in patients with prostate cancer : a longitudinal study
(
- Contribution to journal › Article
-
Mark
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
(
- Contribution to journal › Article
-
Mark
Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone : Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above
(
- Contribution to journal › Article
-
Mark
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer : Extended Analysis of the Phase 3 PREVAIL Study
(
- Contribution to journal › Article
-
Mark
Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele
(
- Contribution to journal › Article
-
Mark
Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting
(
- Contribution to journal › Article
-
Mark
Testosterone suppression with a unique form of leuprorelin acetate as a solid biodegradable implant in patients with advanced prostate cancer : results from four trials and comparison with the traditional leuprorelin acetate microspheres formulation
(
- Contribution to journal › Article
-
Mark
Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Expression of STAT3 in Prostate Cancer Metastases
(
- Contribution to journal › Article
-
Mark
Identification of a Novel Autoimmune Peptide Epitope of Prostein in Prostate Cancer
(
- Contribution to journal › Article
-
Mark
How badly did it hit? Self-assessed emotional shock upon prostate cancer diagnosis and psychological well-being : a follow-up at 3, 12, and 24 months after surgery
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis
(
- Contribution to journal › Article
- 2016
-
Mark
Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
(
- Contribution to journal › Article
-
Mark
Radioimmunotherapy for Prostate Cancer-Current Status and Future Possibilities.
(
- Contribution to journal › Scientific review
-
Mark
Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Oncologic and functional outcomes 1 year after radical prostatectomy for very low risk prostate cancer. Results from the prospective LAPPRO trial.
(
- Contribution to journal › Article
-
Mark
Low β2-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism.
(
- Contribution to journal › Article
-
Mark
PBX3 is a putative biomarker of aggressive prostate cancer
(
- Contribution to journal › Article
-
Mark
Preparedness for side effects and bother in symptomatic men after radical prostatectomy in a prospective, non-randomized trial, LAPPRO
(
- Contribution to journal › Article
-
Mark
Psychological Well-being and Private and Professional Psychosocial Support After Prostate Cancer Surgery : A Follow-up at 3, 12, and 24 Months After Surgery
(
- Contribution to journal › Article
-
Mark
Expression of the TPa and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer : Clinical significance and diagnostic potential
(
- Contribution to journal › Article
-
Mark
Preclinical Characterization of 3β-(N-Acetyl l -cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Validation of novel biomarkers for prostate cancer progression by the combination of bioinformatics, clinical and functional studies
(
- Contribution to journal › Article
-
Mark
The prognostic impact of NK/NKT cell density in periampullary adenocarcinoma differs by morphological type and adjuvant treatment
(
- Contribution to journal › Article
-
Mark
Making Predictive Biomarkers Readily Available
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections
(
- Contribution to journal › Article
-
Mark
Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort
(
- Contribution to journal › Article
-
Mark
A preanalytic validation study of automated bone scan index : Effect on accuracy and reproducibility due to the procedural variabilities in bone scan image acquisition
(
- Contribution to journal › Article
-
Mark
The Proteome of Primary Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.
(
- Contribution to journal › Article
-
Mark
Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer : A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice
(
- Contribution to journal › Article
-
Mark
Bone Scan Index and Progression-free Survival Data for Progressive Metastatic Castration-resistant Prostate Cancer Patients Who Received ODM-201 in the ARADES Multicentre Study
(
- Contribution to journal › Article
-
Mark
Accurate prediction tools in prostate cancer require consistent assessment of included variables
(
- Contribution to journal › Article
-
Mark
The Molecular Evolution of Castration-resistant Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Re : The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
Re: Activity and Safety of ODM-201 in Patients with Progressive Metastatic Castration-resistant Prostate Cancer (ARADES): An Open-label Phase 1 Dose-escalation and Randomised Phase 2 Dose Expansion Trial
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
(
- Contribution to journal › Article
-
Mark
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.
(
- Contribution to journal › Article
-
Mark
Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.
(
- Contribution to journal › Article
-
Mark
Thromboembolic complications in 3544 patients undergoing radical prostatectomy with or without lymph node dissection.
(
- Contribution to journal › Article
-
Mark
Relationship Between Serum Response Factor and Androgen Receptor in Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution.
(
- Contribution to journal › Article
-
Mark
Degree of Preservation of the Neurovascular Bundles During Radical Prostatectomy and Urinary Continence 1 Year after Surgery.
(
- Contribution to journal › Article
-
Mark
Genomic Predictors of Outcome in Prostate Cancer.
(
- Contribution to journal › Scientific review
-
Mark
The Prostate Cancer Registry: Analysis of Medical Resource Utilisation (Mru) in An International, Prospective, Observational Study of Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc).
(
- Contribution to journal › Article
-
Mark
A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.
2015) In European Urology(
- Contribution to journal › Article
-
Mark
Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers
(
- Contribution to journal › Article
-
Mark
Quantitative imaging by automated bone scan index (BSI) as a response biomarker in standard clinical care of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide
2015) American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium In Journal of Clinical Oncology 33(7 Suppl). p.288-288(
- Contribution to journal › Published meeting abstract
-
Mark
Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.
(
- Contribution to journal › Article
-
Mark
Short-term Results after Robot-assisted Laparoscopic Radical Prostatectomy Compared to Open Radical Prostatectomy.
(
- Contribution to journal › Article
- 2014
-
Mark
Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.
(
- Contribution to journal › Article
-
Mark
Burden of Illness in Prostate Cancer Patients with a Low-to-Moderate Risk of Progression: A One-Year, Pan-European Observational Study.
(
- Contribution to journal › Article
-
Mark
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.
(
- Contribution to journal › Article
-
Mark
Androgen receptor polymorphism dependent variation in prostate specific antigen concentrations of European men.
(
- Contribution to journal › Article
-
Mark
Identification of plasma protein profiles associated with risk groups of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
(
- Contribution to journal › Article
-
Mark
Galiellalactone is a Direct Inhibitor of STAT3 in Prostate Cancer Cells.
(
- Contribution to journal › Article
-
Mark
Plasma alkylresorcinol metabolites as biomarkers for whole-grain intake and their association with prostate cancer: a Swedish nested case-control study.
(
- Contribution to journal › Article
-
Mark
The fungal metabolite galiellalactone interferes with the nuclear import of NF-κB and inhibits HIV-1 replication.
(
- Contribution to journal › Article
-
Mark
Interobserver variability in the pathological assessment of radical prostatectomy specimens: Findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study.
(
- Contribution to journal › Article
-
Mark
Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.
(
- Contribution to journal › Article
-
Mark
Cancer-associated Changes in the Expression of TMPRSS2-ERG, PCA3, and SPINK1 in Histologically Benign Tissue From Cancerous vs Noncancerous Prostatectomy Specimens.
(
- Contribution to journal › Article
- 2013
-
Mark
Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1.
(
- Contribution to journal › Article
-
Mark
Automatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections
(
- Contribution to journal › Article
-
Mark
Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
(
- Contribution to journal › Article
-
Mark
Copy number variants in the kallikrein gene cluster.
(
- Contribution to journal › Article
-
Mark
A Systematic Review of the Volume-Outcome Relationship for Radical Prostatectomy
(
- Contribution to journal › Scientific review
-
Mark
Midkine is part of the antibacterial activity released at the surface of differentiated bronchial epithelial cells
(
- Contribution to journal › Article
-
Mark
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
High Expression of Midkine in the Airways of Patients with Cystic Fibrosis.
(
- Contribution to journal › Article
-
Mark
Next-generation Prostate-specific Antigen Test: Ready To Use?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Low expression of SHP-2 is associated with less favorable prostate cancer outcomes.
(
- Contribution to journal › Article
-
Mark
Modeling Costs for Prostate Surgery: Are We Close to Reality?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.
(
- Contribution to journal › Article
-
Mark
Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer.
(
- Contribution to journal › Article
-
Mark
The tumour suppressor miR-34c targets MET in prostate cancer cells.
(
- Contribution to journal › Article
-
Mark
A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.
(
- Contribution to journal › Article
-
Mark
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
(
- Contribution to journal › Article
-
Mark
The Mutational Landscape of Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Carbon Monoxide Expedites Metabolic Exhaustion to Inhibit Tumor Growth
(
- Contribution to journal › Article
- 2012
-
Mark
Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.
(
- Contribution to journal › Article
-
Mark
Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer
(
- Contribution to journal › Article
-
Mark
beta 2-syntrophin and Par-3 promote an apicobasal Rac activity gradient at cell-cell junctions by differentially regulating Tiam1 activity
(
- Contribution to journal › Article
-
Mark
"A Robot Saved My Life": Is It a Myth?
(
- Contribution to journal › Letter
-
Mark
Evaluation of Multiple Risk-Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
(
- Contribution to journal › Article
-
Mark
A Compartmental Model for Biokinetics and Dosimetry of 18F-Choline in Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Dietary intakes of carbohydrates in relation to prostate cancer risk: a prospective study in the Malmo Diet and Cancer cohort.
(
- Contribution to journal › Article
-
Mark
A Contemporary Update on Pathology Reporting for Prostate Cancer: Biopsy and Radical Prostatectomy Specimens
(
- Contribution to journal › Scientific review
-
Mark
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index.
(
- Contribution to journal › Article
- 2011
-
Mark
Tumor markers in prostate cancer I: Blood-based markers
(
- Contribution to journal › Scientific review
-
Mark
Tumour markers in prostate cancer III: Biomarkers in urine
(
- Contribution to journal › Scientific review
-
Mark
Role of histopathology and molecular markers in the active surveillance of prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients
(
- Contribution to journal › Article
-
Mark
Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
2011) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 24. p.708-719(
- Contribution to journal › Article
-
Mark
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
(
- Contribution to journal › Article
-
Mark
CRISP-3 AND B-MSP ON PROSTATE CANCER NEEDLE-BIOPSIES DO NOT HAVE PREDICTIVE VALUE FOR SUBSEQUENT PROSTATECTOMY OUTCOME
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.237-238(
- Contribution to journal › Published meeting abstract
-
Mark
The Contemporary Concept of Significant Versus Insignificant Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Elevated level of wnt5a protein in localized prostate cancer tissue is associated with better outcome.
(
- Contribution to journal › Article
-
Mark
Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50
(
- Contribution to journal › Article
-
Mark
Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.
(
- Contribution to journal › Article
-
Mark
Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors.
(
- Contribution to journal › Article
-
Mark
SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas.
(
- Contribution to journal › Article
-
Mark
Multicomponent Moraxella catarrhalis outer membrane vesicles induce an inflammatory response and are internalized by human epithelial cells.
(
- Contribution to journal › Article
-
Mark
Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
(
- Contribution to journal › Article
-
Mark
Dogs Sniffing Urine: A Future Diagnostic Tool or a Way to Identify New Prostate Cancer Markers?
(
- Contribution to journal › Article
-
Mark
Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder.
2011) In World Journal of Urology(
- Contribution to journal › Article
-
Mark
Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
(
- Contribution to journal › Article
-
Mark
Circulating Tumour Cells as Surrogate Biomarkers in Castration-Resistant Prostate Cancer Trials.
(
- Contribution to journal › Article
-
Mark
Genetic Markers and the Risk of Developing Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
AUTOMATED IMAGE ANALYSIS CONFIRMS THE PREDICTIVE SIGNIFICANCE OF MSMB IN PROSTATE CANCER
(
- Contribution to journal › Published meeting abstract
-
Mark
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
(
- Contribution to journal › Article
-
Mark
Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells.
(
- Contribution to journal › Article
-
Mark
Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells.
(
- Contribution to journal › Article
-
Mark
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
(
- Contribution to journal › Article
- 2010
-
Mark
Validation study of the prognostic significance of beta-microseminoprotein and cysteine-rich secretory protein-3 after radical prostatectomy using automated image analysis
2010) 21st Meeting of the European-Association-for-Cancer-Research In EJC Supplements 8(5). p.136-136(
- Contribution to journal › Published meeting abstract
-
Mark
The Learning Curve for Laparoscopic Radical Prostatectomy: An International Multicenter Study
(
- Contribution to journal › Article
-
Mark
Downsides of Robot-assisted Laparoscopic Radical Prostatectomy: Limitations and Complications
(
- Contribution to journal › Article
-
Mark
Toward Next Generation Plasma Profiling via Heat-induced Epitope Retrieval and Array-based Assays
(
- Contribution to journal › Article
-
Mark
Molecular Pathways in the Progression of Hormone-Independent and Metastatic Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Biokinetics Of 18F-Choline Studied In Four Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions.
(
- Contribution to journal › Article
-
Mark
Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
(
- Contribution to journal › Article
-
Mark
PCA3 as a diagnostic marker for prostate cancer: A validation study on a Swedish patient population.
(
- Contribution to journal › Article
-
Mark
Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
(
- Contribution to journal › Article
-
Mark
Male infertility and prostate cancer risk: a nested case-control study.
(
- Contribution to journal › Article
-
Mark
Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
(
- Contribution to journal › Article
-
Mark
BIOKINETICS AND DOSIMETRY FOR 18F-CHOLINE IN PROSTATE CANCER PATIENTS
2010) 5th Annual Malmö Cancer Center Retreat(
- Contribution to conference › Abstract
-
Mark
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer : Case-control study
(
- Contribution to journal › Article